Neuropore Therapies (NPT) Announces Achievement of Key Program Milestone

SAN DIEGO--(BUSINESS WIRE)--Neuropore Therapies, Inc. announced today that they have successfully achieved a key program milestone in their collaboration with UCB. After successful completion of a randomized, double-blind, placebo controlled single ascending dose clinical study and additional non-clinical studies, UCB has awarded NPTTM a progression milestone of $5 million. "We are very pleased with UCB’s decision to proceed with the development of this novel therapeutic candidate that initiall